Meunier, M., Thepot, S., Nimubona, S., Veloso, M., Lefebvre, T., Karim, Z., Ropert-Bouchet, M., Garban, F., Amé, S., Reynes, C., Salanoubat, C., Parinet, V., Laribi, K., Eftekhari, P., Delaunay, J., Venton, G., Santana, C., Cheze, S., Dimicoli-Salazar, S., Toma, A., Molimard, M., Fenaux, P., Rolland-Neyret, V., David-Tchouda, S. and Park, S. (2020) “Low-dose deferasirox for lower-risk myelodysplastic syndromes after erythropoiesis-stimulating agents (ESA) failure: results of the phase II LODEFI study”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2026.301420.